Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials
- DOI
- 10.1007/s40263-026-01334-4
- Published
- 2026-09-23
- Container
- CNS Drugs
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40263-026-01334-4,
title = {Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials},
author = {Itai Danovitch and Kyla Truman and Haze Brown and Macie Miller and Shaishav Shah and Jayant Totlani and Daniel N. Kaidbay and Kaleab K. Tessema and Zholi Minasyan and Waguih William IsHak and Samuel Miles and Robert N. Pechnick},
year = {2026},
journal = {CNS Drugs},
doi = {10.1007/s40263-026-01334-4},
url = {https://doi.org/10.1007/s40263-026-01334-4}
}RIS
TY - JOUR TI - Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials AU - Itai Danovitch AU - Kyla Truman AU - Haze Brown AU - Macie Miller AU - Shaishav Shah AU - Jayant Totlani AU - Daniel N. Kaidbay AU - Kaleab K. Tessema AU - Zholi Minasyan AU - Waguih William IsHak AU - Samuel Miles AU - Robert N. Pechnick PY - 2026 JO - CNS Drugs DO - 10.1007/s40263-026-01334-4 UR - https://doi.org/10.1007/s40263-026-01334-4 ER -
APA
Danovitch, I., Truman, K., Brown, H., Miller, M., Shah, S., Totlani, J., Kaidbay, D. N., Tessema, K. K., Minasyan, Z., IsHak, W. W., Miles, S., & Pechnick, R. N. (2026). Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials. CNS Drugs. https://doi.org/10.1007/s40263-026-01334-4
Source records
- crossref · retrieved 2026-09-25T05:23:59.066Z